Abstract
Lung cancer is a disease with very high morbidity and mortality rate. In spite of aggressive treatment modalities, the long- term survival is very low, and these treatments have many toxic adverse effects. Immunological therapies or briefly “immunotherapy” is a promising new therapeutic modality for lung cancer; it can be in the form of active immunization (cancer vaccines), passive immunization (adoptive cell therapy or antibody-based treatment) or immunostimulation.
Keywords: Lung cancer, immunotherapy, vaccine, antibody-based treatment, cetuximab, bevacizumab, panitumumab, matuzumab, pertuzumab, transtuzumab, erlotinin, paclitaxel, carboplatin, gemtuzumab, GVAX, MUC1, MAGE-A3, TG4010.
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Current Radiopharmaceuticals
Recent Patents on Anti-Cancer Drug Discovery
Current Medicinal Chemistry - Anti-Cancer Agents
Current Cancer Therapy Reviews
Clinical Cancer Drugs
Anti-Cancer Agents in Medicinal Chemistry
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents